Education
About Us
Working with TipRanks
Follow Us
Ampio Pharmaceuticals (AMPE)
OTHER OTC:AMPE
Total Valuation
Ampio Pharmaceuticals has a market cap or net worth of $22.71K. The enterprise value is -$2.12M.
Market Cap$22.71K
Enterprise Value-$2.12M
Share Statistics
Ampio Pharmaceuticals has 1,135,358 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,135,358
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ampio Pharmaceuticals’s return on equity (ROE) is -2.57 and return on invested capital (ROIC) is -252.47%.
Return on Equity (ROE)-2.57
Return on Assets (ROA)-1.50
Return on Invested Capital (ROIC)-252.47%
Return on Capital Employed (ROCE)-2.83
Revenue Per Employee0.00
Profits Per Employee-1.44M
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ampio Pharmaceuticals is ―. Ampio Pharmaceuticals’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio0.49
Price to Fair Value0.49
Price to FCF-0.19
Price to Operating Cash Flow>-0.01
PEG Ratio0.04
Income Statement
In the last 12 months, Ampio Pharmaceuticals had revenue of 0.00 and earned -8.63M in profits. Earnings per share was -10.67.
Revenue0.00
Gross Profit-250.00K
Operating Income-9.52M
Pretax Income-8.63M
Net Income-8.63M
EBITDA-8.38M
Earnings Per Share (EPS)-10.67
Cash Flow
In the last 12 months, operating cash flow was -8.56M and capital expenditures 0.00, giving a free cash flow of -8.56M billion.
Operating Cash Flow-8.56M
Free Cash Flow-8.56M
Free Cash Flow per Share-7.54
Dividends & Yields
Ampio Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.68
52-Week Price Change-77.78%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)42.32
Average Volume (3m)1.58K
Important Dates
Ampio Pharmaceuticals upcoming earnings date is May 9, 2024, TBA (Confirmed).
Last Earnings DateMay 11, 2023
Next Earnings DateMay 9, 2024
Ex-Dividend Date―
Financial Position
Ampio Pharmaceuticals as a current ratio of 2.41, with Debt / Equity ratio of 8.15%
Current Ratio2.41
Quick Ratio2.41
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Ampio Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Ampio Pharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.25.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.25
EV to Operating Cash Flow0.25
Balance Sheet
Ampio Pharmaceuticals has $4.09M in cash and marketable securities with $274.00K in debt, giving a net cash position of $3.81M billion.
Cash & Marketable Securities$4.09M
Total Debt$274.00K
Net Cash$3.81M
Net Cash Per Share$3.36
Tangible Book Value Per Share$4.15
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Ampio Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―